Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...

Long-term Potentiation

Long-term Potentiation

Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre- and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.

Long-term Potentiation

Long-term Potentiation

Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when presynaptic neurons...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

Parkinson Disease l: Introduction

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

GOATEA: gene set enrichment analysis in R with shiny interactive visualizations.

BMC bioinformatics·2026

Same author

Discovery of a Highly Potent and Efficient BRD9 Degrader with Strong <i>In Vivo</i> Antitumor Activity.

Journal of medicinal chemistry·2026

Same author

The intestine as a nexus of tissue-encoded immunological memory.

International immunology·2026

Same author

The IL-10/IL-10Rα axis in fibroblasts limits large intestinal pathology by suppressing type I interferon signaling.

International immunology·2026

Same author

Reprogramming the gut immune system: featured advances in intestinal immunity in 2025.

Immunology and cell biology·2026

Same author

Genetic vitamin B6 deficiency exacerbates alcohol behavioral responses, metabolism, and toxicity in Drosophila.

Human molecular genetics·2026

Search research articles

Related Experiment Video

Updated: Jun 13, 2026

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

Dopamine-dependent motor learning: insight into levodopa's long-duration response.

Jeff A Beeler¹, Zhen Fang Huang Cao, Mazen A Kheirbek

¹Department of Neurobiology, University of Chicago, Chicago, IL 60637, USA. jabeeler@uchicago.edu

Annals of Neurology

|May 4, 2010

Summary

Dopamine deficiency impairs motor learning in mice, but levodopa treatment rescues this deficit. Motor skill improvements persist after treatment cessation, suggesting motor learning

More Related Videos

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

Related Experiment Videos

Last Updated: Jun 13, 2026

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

Area of Science:

Neuroscience
Motor Control
Neuropharmacology

Background:

Dopamine (DA) is crucial for motor performance, learning, and corticostriatal plasticity.
The precise role of DA in mediating motor performance and learning remains incompletely understood.

Purpose of the Study:

To investigate the relationship between motor performance and learning.
To elucidate the role of dopamine in mediating motor skill acquisition and retention.

Main Methods:

Utilized PITx3-deficient mice (aphakia mice) with a 90% reduction in dorsal striatal dopamine.
Assessed motor learning using the accelerating rotarod task.
Investigated the effects of levodopa treatment and its cessation on motor performance.

Main Results:

PITx3-deficient mice exhibited significant deficits in motor skill learning.
Levodopa treatment successfully rescued motor learning impairments.
Performance decline after levodopa cessation was gradual and dependent on retesting, not pharmacokinetics.

Conclusions:

Motor learning may play a critical, underappreciated role in Parkinson disease symptomatology and levodopa's therapeutic effects.
The long-duration response to levodopa therapy likely represents rescued motor learning.
This suggests motor learning is a key factor in the sustained benefits of levodopa treatment.